BIOCON
|
The Current P/B Ratio of BIOCON is 2.09.
Share Price | ₹339.2 | Apr 01,2025 |
Market Cap | ₹40,718.3 Cr | |
Book Value | ₹19,463.6 Cr | Mar2024 - Consolidated Results |
Price/Book | 2.09x | Calculated as MarketCap/Book Value |
---|---|---|
Explore Stock Analytics |
Definition & Calculation of PB (Price/Book ) ratio of BIOCON
P/B =
Market Capitalization
/ Book Value
or, using per-share numbers:
P/B = Stock Price /
Book Value Per Share
Current Market Cap [ ₹40,718.3 Cr] as on Apr 01,2025
(/) Book Value [ ₹19,463.6 Cr] based on Mar2024 - Consolidated Results
(=) P/B Ratio [ 2.09x ]
Thus, for BIOCON , the investors are currently willing to pay '2.09 times book value' to own 1 share of the company.
PB Multiples are one of the most widely used valuation multiple in industry.
Since P/B ratio uses Book Value in the calculation, P/B multiples are not always reliable for valuing companies with negative book value.
In such cases, you may consider using Price to Earnings ratio or Price to Sales ratio of BIOCON !
The chart below summarizes the trend in P/B Ratio of BIOCON over the last five years.
Historical PB (Price/Book ) ratio chart of BIOCON
PB Ratio Performance Analysis for BIOCON
- BIOCON 's p/b ratio for fiscal years ending Mar2024 to Mar2020 averaged 3.88x.
- BIOCON 's operated at median p/b ratio of 4.88x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, BIOCON 's p/b ratio peaked in Mar2021 at 6.57x.
- BIOCON 's p/b ratio hit its five-year low in Mar2023 of 1.41x.
How does BIOCON 's P/B Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
Peer Comparison (Pharmaceuticals & Drugs Industry) | Book Value | PB Ratio | Market Cap |
---|---|---|---|
BIOCON | 19,463.60 | 2.09 | 40,718.3 |
SUN PHARMACEUTICAL INDUSTRIES LTD | 63,666.80 | 6.40 | 407,155.0 |
DIVIS LABORATORIES LTD | 13,571.00 | 10.85 | 147,295.0 |
CIPLA LTD | 26,619.90 | 4.38 | 116,664.0 |
TORRENT PHARMACEUTICALS LTD | 6,856.15 | 15.71 | 107,678.0 |
DR REDDYS LABORATORIES LTD | 28,123.50 | 3.42 | 96,162.6 |
MANKIND PHARMA LTD | 9,339.84 | 10.85 | 101,358.0 |
ZYDUS LIFESCIENCES LTD | 19,829.50 | 4.45 | 88,297.0 |
LUPIN LTD | 14,175.80 | 6.30 | 89,322.4 |
AUROBINDO PHARMA LTD | 29,842.80 | 2.21 | 65,912.3 |
ABBOTT INDIA LTD | 3,658.73 | 17.60 | 64,397.8 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PB Analysis vs BIOCON 's P/B Ratio
Top 10 Industry Peers | PB Ratio |
---|---|
Min industry PB | 2.09x |
Max industry PB | 17.60x |
Median industry PB | 6.30x |
Average industry PB | 7.66x |
You may also like the below Video Courses